梨 (Persea americana) 皮:一个有希望的生物活性化合物的来源
Morenikeji Abel Oke1,2,3, Elijah Adegoke Adebayo1,2,4, Nathaniel Aanu Ajisope1,2
1Department of Pure and Applied Biology, Ladoke Akintola University, Ogbomoso, Nigeria.
Frontiers in nutrition
|October 17, 2025
概括
梨皮 (AVDP) 的废物是丰富的营养素和生物活性化合物的来源. 提升这种农业副产品的价值为食品和药物行业提供了巨大的潜力.
科学领域:
- 农业科学 农业科学
- 食品科学 食品科学 食品科学
- 生物化学 生物化学
背景情况:
- 全球对Persea americana (PA) 果实需求的增加产生了大量的梨皮 (AVDP) 废物.
- 尽管AVDP含有丰富的营养和生物活性成分,但它经常被丢弃,这给环境带来了挑战.
- 本综述探讨了AVDP作为一个有价值的资源的潜力.
研究的目的:
- 审查梨皮的营养特征和生物活性成分 (AVDP).
- 探索AVDP的药理性质和食品工业应用.
- 突出AVDP价值化对于可持续工业用途的必要性.
主要方法:
- 文献综述侧重于分析AVDP组成的研究.
- 关于AVDP化合物的药理活性研究的汇编.
- 综合有关食品工业中AVDP应用的信息.
主要成果:
- AVDP含有大量的多,黄,有机酸和各种衍生物.
- 营养分析显示AVDP中的蛋白质,碳水化合物,脂质,纤维和灰.
- 药理性质包括抗氧化,抗炎和抗菌活性.
结论:
- AVDP是生物活性化合物的宝贵来源,具有多种健康益处.
- 它的营养成分支持其作为功能性食品,添加剂和防腐剂的应用.
- 对AVDP废物的利用对于可持续的工业和医疗应用至关重要.
更多相关视频
相关概念视频
Fruit Development, Structure, and Function
24.9K
Fruits form from a mature flower ovary. As seeds develop from the ovules contained within, the ovary wall undergoes a series of complex changes to form fruit. In some fruits, such as soybeans, the ovary wall dries; in other fruits, such as grapes, it remains fleshy. In some cases, organs other than the ovary contribute to fruit formation; such fruits are called accessory fruits.
24.9K
Bioavailability: Overview
4.1K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
4.1K
Bioavailability: Overview
355
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
355
Factors Influencing Bioavailability: First-Pass Elimination
7.9K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
7.9K
Bioavailability: Influencing Factors
334
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
334
Bioavailability Enhancement: Drug Permeability Enhancement
184
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
184


